Stock Events

BioPharma Credit 

GBX65.9
51
-GBX2.3-3.38% Thursday 12:17

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
8.01%
Dividend
5.28

Upcoming

29
OCT
Dividend Payment
Decreased
 
29
OCT
Dividend Payment
Increased
 
15
FEB 25
Dividend Ex
Estimated
 
15
MAR 25
Dividend Payment
Estimated
 
28
MAR 25
Dividend Ex
Estimated
 
30
APR 25
Dividend Payment
Estimated
 
4
JUL 25
Dividend Ex
Estimated
 
31
JUL 25
Dividend Payment
Estimated
 
26
SEP 25
Dividend Ex
Estimated
 
29
OCT 25
Dividend Payment
Estimated
 

Dividends

8.01%Dividend Yield
Oct 24
GBX1.32
Oct 24
GBX1.52
Jul 24
GBX1.32
Apr 24
GBX1.37
Mar 24
GBX0.94
10Y Growth
N/A
5Y Growth
-5.84%
3Y Growth
-7.41%
1Y Growth
-27.22%

Earnings

25SepExpected
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Q2 2024
0.03
0.04
0.04
0.05
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BPCP.LSE. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap5.24B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck
MRK
Mkt Cap300.25B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap179.38B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap244.75B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap141.43B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Show more...
CEO
Country
GB
ISIN
GB00BDGKMY29

Listings

F
DE
B3P.F
LSE
GB
BPCP.LSE
US
BOPCF
LSE
GB
BPCR.LSE